LENEE CAYABYAB: Open Payments
NPI 1558639716 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $720 · 2025 $559
Food & beverage: $544Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $176 |
| Janssen Biotech, Inc. | 3 | $113 |
| Incyte Corporation | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Biofrontera Inc. | 2 | $41 |
| LEO Pharma Inc. | 1 | $31 |
| UCB, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $24 |
| PFIZER INC. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: SKYRIZI, TREMFYA, OPZELURA, DUPIXENT, RINVOQ, ANZUPGO, Bimzelx, EBGLYSS.
Industry payments across CA — which companies pay providers there.
